Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OTIPRIO in acute otitis externa
NCT02801370Phase 3Completed
- Sponsor
- Otonomy, Inc.
- Start
- Jun 2016
- Primary completion
- Nov 2016
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of ciprofloxacin + fluocinolone acetonide in acute otitis externa (AOE) (2 arms), sponsored by Otonomy, Inc. Primary endpoint: Number of Subjects Considered a Clinical Cure at Day 8. Started Jun 2016; status: completed.
02
Drugs
ciprofloxacin + fluocinolone acetonide
03
Conditions
acute otitis externa (AOE)
Beyond the preview
Go deeper on NCT02801370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02801370.